|Last Price$97.92||Day Change (%)4.70%|
|Open Price$93.73||Day Change ($)4.40|
|Day Range93.63–98.88||52-Week Range47.03–112.57|
As of Fri 12/26/2014 04:59 PM EST | USD
Alnylam Files Clinical Trial Application (CTA) for ALN-CC5, an RNAi Therapeutic Targeting Complement C5 in Development for the Treatment of Complement-Mediated Diseases
Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.